WeVote

Bill

Bill

AB 54

Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

2025-2026 Regular Session Introduced by Rick Gundrum and 6 co-sponsors

Overview: AB 54, a bill relating to utilization management controls for antipsychotic prescription drugs under the Medical Assistance program, received a fiscal estimate on Decembe

Fiscal estimate received
0
WeVote Research Nonpartisan
Bill Summary · AB 54

Overview: AB 54, a bill relating to utilization management controls for antipsychotic prescription drugs under the Medical Assistance program, received a fiscal estimate on December 02, 2024.

Purpose and Intent: The bill aims to address concerns about the overuse and inappropriate prescription of antipsychotic medications for individuals enrolled in the state's Medical Assistance program, which provides healthcare coverage for low-income residents.

Key Provisions:
- Requires the state's Medicaid program to implement utilization management controls for the prescription of antipsychotic drugs, including prior authorization requirements and limits on the duration of treatment.
- Mandates the development of clinical guidelines and protocols to ensure the appropriate use of antipsychotic medications, based on evidence-based best practices.
- Establishes a monitoring and reporting system to track the prescribing patterns of healthcare providers and identify potential misuse or overutilization of antipsychotic drugs.
- Provides for the implementation of educational programs and resources to help healthcare providers and patients make informed decisions about the use of antipsychotic medications.

Affected Parties and Impacts: The bill would primarily affect individuals enrolled in the state's Medical Assistance program who are prescribed antipsychotic medications, as well as the healthcare providers who prescribe these drugs. The new utilization management controls could lead to increased oversight and potentially limit access to certain antipsychotic medications, but proponents argue that this is necessary to ensure the safe and appropriate use of these powerful drugs.

Procedural and Timeline Considerations: The bill has received a fiscal estimate, indicating that it has progressed through the legislative process. However, its current status and next steps are unclear from the information provided.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.